|
VMA21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.664000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.695800E-01 |
| Normal-vs-Stage2 |
2.042800E-01 |
| Normal-vs-Stage3 |
2.060700E-03 |
| Normal-vs-Stage4 |
6.357800E-02 |
| Stage1-vs-Stage2 |
2.981400E-01 |
| Stage1-vs-Stage3 |
7.282200E-03 |
| Stage1-vs-Stage4 |
4.846500E-02 |
| Stage2-vs-Stage3 |
7.783800E-01 |
| Stage2-vs-Stage4 |
9.800800E-01 |
| Stage3-vs-Stage4 |
7.409200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.284310E-02 |
| Normal-vs-AfricanAmerican |
4.115500E-02 |
| Normal-vs-Asian |
3.637400E-01 |
| Caucasian-vs-AfricanAmerican |
4.262600E-01 |
| Caucasian-vs-Asian |
5.758600E-01 |
| AfricanAmerican-vs-Asian |
9.200200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.115600E-02 |
| Normal-vs-Female |
6.813600E-04 |
| Male-vs-Female |
9.458600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.597800E-02 |
| Normal-vs-Extreme_Weight |
9.136200E-02 |
| Normal-vs-Obese |
1.218330E-02 |
| Normal-vs-Extreme_Obese |
5.862800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.250200E-01 |
| Normal_Weight-vs-Obese |
5.068000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.923600E-02 |
| Extreme_Weight-vs-Obese |
1.339790E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.652200E-01 |
| Obese-vs-Extreme_Obese |
1.636120E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.597500E-03 |
| Normal-vs-Age(41-60Yrs) |
7.55080000000019E-05 |
| Normal-vs-Age(61-80Yrs) |
3.620400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.175000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.611000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.814100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.502000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.917500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.334200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.595200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.955200E-03 |
| Normal-VS-Type2 PRCC |
1.767030E-01 |
| Normal-VS-KIRP CIMP |
3.285700E-02 |
| Normal-VS-Unclassified PRCC |
6.040000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.379400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.316800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.745600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.315430E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.869600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.787630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.389200E-01 |
| Normal-vs-N1 |
6.262700E-03 |
| Normal-vs-N2 |
4.07229999999092E-06 |
| N0-vs-N1 |
3.342200E-02 |
| N0-vs-N2 |
2.340000E-02 |
| N1-vs-N2 |
3.352800E-01 |
|
|
